Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system

Giancarlo Icardi, Andrea Orsi, Antonella Ceravolo, Filippo Ansaldi

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Among the several strategies explored for (1) the enhancement of the immune response to influenza immunization, (2) the improvement of the vaccine acceptability and (3) the overcoming of the egg-dependency for vaccine production, intradermal administration of influenza vaccine emerges as a promising alternative to conventional intramuscular route, thanks to the recent availability of new delivery devices and the perception of advantages in terms of immunogenicity, safety, reduction of antigen content and acceptability. Data from clinical trials performed in children, adults

Original languageEnglish
Pages (from-to)67-75
Number of pages9
JournalHuman Vaccines and Immunotherapeutics
Volume8
Issue number1
Publication statusPublished - Jan 2012

Fingerprint

Influenza Vaccines
Vaccines
Injections
Human Influenza
Ovum
Immunization
Clinical Trials
Safety
Antigens
Equipment and Supplies
Dependency (Psychology)

Keywords

  • Acceptability
  • Immunogenicity
  • Influenza vaccine
  • Intradermal
  • Micro injection system
  • Safety
  • Tolerability

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology

Cite this

Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system. / Icardi, Giancarlo; Orsi, Andrea; Ceravolo, Antonella; Ansaldi, Filippo.

In: Human Vaccines and Immunotherapeutics, Vol. 8, No. 1, 01.2012, p. 67-75.

Research output: Contribution to journalArticle

Icardi, Giancarlo ; Orsi, Andrea ; Ceravolo, Antonella ; Ansaldi, Filippo. / Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system. In: Human Vaccines and Immunotherapeutics. 2012 ; Vol. 8, No. 1. pp. 67-75.
@article{9b2440272fd94384b4ad70aae95d3ba1,
title = "Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system",
abstract = "Among the several strategies explored for (1) the enhancement of the immune response to influenza immunization, (2) the improvement of the vaccine acceptability and (3) the overcoming of the egg-dependency for vaccine production, intradermal administration of influenza vaccine emerges as a promising alternative to conventional intramuscular route, thanks to the recent availability of new delivery devices and the perception of advantages in terms of immunogenicity, safety, reduction of antigen content and acceptability. Data from clinical trials performed in children, adults",
keywords = "Acceptability, Immunogenicity, Influenza vaccine, Intradermal, Micro injection system, Safety, Tolerability",
author = "Giancarlo Icardi and Andrea Orsi and Antonella Ceravolo and Filippo Ansaldi",
year = "2012",
month = "1",
language = "English",
volume = "8",
pages = "67--75",
journal = "Human Vaccines and Immunotherapeutics",
issn = "2164-5515",
publisher = "Taylor and Francis Inc.",
number = "1",

}

TY - JOUR

T1 - Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system

AU - Icardi, Giancarlo

AU - Orsi, Andrea

AU - Ceravolo, Antonella

AU - Ansaldi, Filippo

PY - 2012/1

Y1 - 2012/1

N2 - Among the several strategies explored for (1) the enhancement of the immune response to influenza immunization, (2) the improvement of the vaccine acceptability and (3) the overcoming of the egg-dependency for vaccine production, intradermal administration of influenza vaccine emerges as a promising alternative to conventional intramuscular route, thanks to the recent availability of new delivery devices and the perception of advantages in terms of immunogenicity, safety, reduction of antigen content and acceptability. Data from clinical trials performed in children, adults

AB - Among the several strategies explored for (1) the enhancement of the immune response to influenza immunization, (2) the improvement of the vaccine acceptability and (3) the overcoming of the egg-dependency for vaccine production, intradermal administration of influenza vaccine emerges as a promising alternative to conventional intramuscular route, thanks to the recent availability of new delivery devices and the perception of advantages in terms of immunogenicity, safety, reduction of antigen content and acceptability. Data from clinical trials performed in children, adults

KW - Acceptability

KW - Immunogenicity

KW - Influenza vaccine

KW - Intradermal

KW - Micro injection system

KW - Safety

KW - Tolerability

UR - http://www.scopus.com/inward/record.url?scp=84861810763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861810763&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 67

EP - 75

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

SN - 2164-5515

IS - 1

ER -